132 related articles for article (PubMed ID: 38638002)
1. CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions.
Tolg C; Hill KA; Turley EA
Adv Biol (Weinh); 2024 Apr; ():e2300693. PubMed ID: 38638002
[TBL] [Abstract][Full Text] [Related]
2. RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.
Tolg C; Milojevic M; Qi FW; Pavanel HA; Locke MEO; Ma J; Price M; Nelson AC; McCarthy JB; Hill KA; Turley EA
Breast Cancer Res; 2023 Jun; 25(1):74. PubMed ID: 37349798
[TBL] [Abstract][Full Text] [Related]
3. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
4. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
[TBL] [Abstract][Full Text] [Related]
5. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.
Misra S; Hascall VC; Markwald RR; Ghatak S
Front Immunol; 2015; 6():201. PubMed ID: 25999946
[TBL] [Abstract][Full Text] [Related]
6. High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer.
Lin A; Feng J; Chen X; Wang D; Wong M; Zhang G; Na J; Zhang T; Chen Z; Chen YT; Nancy Du YC
Cancer Lett; 2021 Aug; 514():79-89. PubMed ID: 34044069
[TBL] [Abstract][Full Text] [Related]
7. How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?
Telmer PG; Tolg C; McCarthy JB; Turley EA
Commun Integr Biol; 2011 Mar; 4(2):182-5. PubMed ID: 21655434
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells.
Veiseh M; Leith SJ; Tolg C; Elhayek SS; Bahrami SB; Collis L; Hamilton S; McCarthy JB; Bissell MJ; Turley E
Front Cell Dev Biol; 2015; 3():63. PubMed ID: 26528478
[TBL] [Abstract][Full Text] [Related]
9. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
Enemark MB; Hybel TE; Madsen C; Lauridsen KL; Honoré B; Plesner TL; Hamilton-Dutoit S; d'Amore F; Ludvigsen M
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267625
[TBL] [Abstract][Full Text] [Related]
11. Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.
Bahrami SB; Tolg C; Peart T; Symonette C; Veiseh M; Umoh JU; Holdsworth DW; McCarthy JB; Luyt LG; Bissell MJ; Yazdani A; Turley EA
Integr Biol (Camb); 2017 Mar; 9(3):223-237. PubMed ID: 28217782
[TBL] [Abstract][Full Text] [Related]
12. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
Wang C; Thor AD; Moore DH; Zhao Y; Kerschmann R; Stern R; Watson PH; Turley EA
Clin Cancer Res; 1998 Mar; 4(3):567-76. PubMed ID: 9533523
[TBL] [Abstract][Full Text] [Related]
14. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
Li H; Guo L; Li JW; Liu N; Qi R; Liu J
Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
[TBL] [Abstract][Full Text] [Related]
15. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
16. RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.
Sohr S; Engeland K
Cell Cycle; 2008 Nov; 7(21):3448-60. PubMed ID: 18971636
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Maxwell CA; McCarthy J; Turley E
J Cell Sci; 2008 Apr; 121(Pt 7):925-32. PubMed ID: 18354082
[TBL] [Abstract][Full Text] [Related]
18. The Role of CD44 and RHAMM in Endometrial (Endometrioid Type) Cancer: An Immunohistochemical Study.
Klarić M; Haller H; Brnčić Fischer A; Babarović E; Prijić A; Eminović S
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):606-612. PubMed ID: 29734248
[TBL] [Abstract][Full Text] [Related]
19. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
20. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
